Financials
- Market Capitalization 226.2 M
- Employee 130
- Founded 2016
- CEO N/A
- Website www.nautilus.bio
- Headquarter Washington, United States
- FIGI BBG00W7G4M12
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.15
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3530 | AGEN Agenus Inc. - Common Stock | 5.24 USD | -14.38% | +48.44% | +55.95% | -23.62% | 218.21 M USD | ||
| 3533 | IVVD Invivyd, Inc. - Common Stock | 0.80 USD | +1.27% | -17.53% | -1.23% | +11.11% | 235.69 M USD | ||
| 3552 | OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 3.76 USD | -1.57% | -5.76% | -8.74% | +23.68% | 225.15 M USD | ||
| 3557 | CHRS Coherus Oncology, Inc. - Common Stock | 1.45 USD | -1.36% | -13.69% | +1.40% | -9.94% | 223.66 M USD |